CMT Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

CMT Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-13,000	Closed	-$759K	–	163
2017 Q2	$724K	Sell	13,000 -34,813	-73%	-$1.89M	0.05%	134
2017 Q1	$2.6M	Sell	47,813 -43,749	-48%	-$2.4M	0.22%	91
2016 Q4	$5.35M	Buy	91,562 +9,519	+12%	+$520K	0.25%	86
2016 Q3	$4.42M	Buy	+82,043	New	+$5.27M	0.2%	96
2016 Q1	–	Sell	-205	Closed	-$12.9K	–	207
2015 Q4	$14K	Buy	+205	New	+$13.5K	﹤0.01%	205
2014 Q4	–	Sell	-4,589	Closed	-$259K	–	177
2014 Q3	$235K	Buy	+4,589	New	+$229K	0.01%	148
2014 Q1	–	Sell	-60,134	Closed	-$3.2M	–	82
2013 Q4	$3.2M	Buy	+60,134	New	+$3.06M	0.16%	91

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CMT Asset Management's BMY Position: Q3 2017 in Review

CMT Asset Management sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 13,000 shares — an estimated $759K sold.

CMT Asset Management first reported a position in BMY in Q4 2013 and held it in 7 quarters. The position peaked at $5.35M in Q4 2016. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

CMT Asset Management reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
CMT Asset Management sold 13,000 Bristol-Myers Squibb shares in Q3 2017, an estimated $759K.
CMT Asset Management first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 7 quarters.
CMT Asset Management's Bristol-Myers Squibb position peaked at $5.35M in Q4 2016.
1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on CMT Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.